Clinical Trials Browser

Hemorrhage

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT06440044 2024-07-15

Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism

Completed

2,000 enrolled

Gastrointestinal

Colonic Neoplasms, Hemorrhage, Venous Thrombosis

NCT04744688 2024-05-29

CONTEST

Completed

90 enrolled

Classical hematologyGastrointestinalGynecologic

Colonic Neoplasms, Hemorrhage, Intestinal Neoplasms, Neoplasms, Peritoneal Neoplasms, Postoperative Complications, Rectal Neoplasms, Thrombosis, Colorectal Neoplasms, Venous Thromboembolism

NCT04985071 2024-05-13

PF

Completed

183 enrolled

Gastrointestinal

Hemorrhage, Pancreatic Fistula

NCT05452538 2024-02-26

ATTRACS

Completed

5,808 enrolled

Hemorrhage

NCT04170231 2023-10-19

Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses

Completed

93 enrolled

Hemorrhage, Neoplasms

NCT02921802 2022-06-14

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Completed

4,626 enrolled

Classical hematologyMyeloidOtherPlasma cell

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myelodysplastic Syndromes, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT02922543 2022-06-14

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Completed

361 enrolled

Classical hematologyOtherPlasma cell

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT03904732 2021-02-01